Yibin Kang is a Warner-Lambert/Parke-Davis Professor of Molecular Biology at Princeton University, a member of the Ludwig Institute for Cancer Research Princeton Branch and an Associate Director of Rutgers Cancer Institute of New Jersey. He graduated with a bachelor’s degree from Fudan University in Shanghai in 1995. After completing his graduate study at Duke in 2000 and postdoctoral training at Memorial Sloan-Kettering Cancer Center, Dr. Kang joined the faculty of Princeton University as an Assistant Professor of Molecular Biology in 2004. He was promoted to Associate Professor with tenure in 2010 and to Endowed Chair Full Professor in 2012. Dr. Kang has served as the President of the Metastasis Research Society (2016-2018), Chair of the American Association for Cancer Research (AACR) Tumor Microenvironment Working Group (2018-2019) and President of Chinese Biological Investigator Society (2018-2022).

Dr. Kang’s research focuses on the molecular mechanisms of breast cancer metastasis. His work discovered new genes that promote recurrence, metastasis and treatment resistance of breast cancer, delineated tumor-stromal interactions that are essential for metastatic growth, and developed novel therapeutics. He has published over 200 original articles in leading journals including Science, Cancer Cell, and Nature Medicine. Dr. Kang's outstanding achievements have been recognized by many prestigious awards, including the 2011 Vicek Prize for Creative Promise in Biomedical Sciences (2011), and the AACR Award for Outstanding Achievements in Cancer Research (2012), and the AACR Outstanding Investigator Award in Breast Cancer Research (2014). Dr. Kang is an AAAS Fellow, a Komen Scholar, and an American Cancer Society Research Professor.

Dr. Kang is a co-Founder of two biotech start-ups focusing on novel cancer therapeutics (Firebrand Therapeutics and KayoThera), based on intellectual properties developed in his laboratory. He is a Boston-qualified marathon runner and triathlete, having completed 12 marathons, including the six World Marathon Majors and an Ironman.